Lipocine (LPCN) EBITDA (2013 - 2025)
Lipocine (LPCN) recorded EBITDA of -$3.35 million in Q3 2025, compared with -$2.62 million a year earlier.
Powered by 
Analysis
Lipocine (LPCN) EBITDA (2013 - 2025) Analysis & Trends
On a TTM basis, Lipocine's EBITDA came in at -$6.25 million as of Sep 30, 2025; for FY2024, it was -$1.11 million.
- Across earlier years, EBITDA came in at -$17.9 million in FY2023, -$12.11 million in FY2022, $3.15 million in FY2021 and -$17.99 million in FY2020.
- The Q3 2025 figure is the lowest quarterly EBITDA since Q3 2023.
- Per Business Quant, the preceding three quarters came in at -$2.39 million (Q2 2025), -$2.07 million (Q1 2025) and $1.56 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -3.35 Mn |
| Jun 30, 2025 | -2.39 Mn |
| Mar 31, 2025 | -2.07 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | -2.62 Mn |
| Jun 30, 2024 | -3.28 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | -2.59 Mn |
| Sep 30, 2023 | -7.04 Mn |
| Jun 30, 2023 | -3.95 Mn |
| Mar 31, 2023 | -4.33 Mn |
| Dec 31, 2022 | -2.56 Mn |
| Sep 30, 2022 | -2.90 Mn |
| Jun 30, 2022 | -3.52 Mn |
| Mar 31, 2022 | -3.13 Mn |
| Mar 31, 2021 | -3.11 Mn |
| Dec 31, 2020 | -4.80 Mn |
| Sep 30, 2020 | -4.37 Mn |
| Jun 30, 2020 | -4.22 Mn |
| Mar 31, 2020 | -4.60 Mn |
API Access
Lipocine EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();